search
Back to results

Flushing of Internalized Percutaneous Transhepatic Biliary Drainage Catheters (FLUSH)

Primary Purpose

Bile Duct Obstruction

Status
Recruiting
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Flushing of PTBD catheter
Sponsored by
Erasmus Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Bile Duct Obstruction focused on measuring bile duct, obstruction

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Patient with obstruction of the bile duct(s) planned for internal external PTBD;

  • Proficient in Dutch language;
  • Written informed consent.

Exclusion Criteria:

  • Age < 18 years;

    • No informed consent;
    • Pregnancy;
    • Obstruction caused by gall stones;
    • External PTBD catheter (without internalization);
    • Patient has already a PTBD catheter;
    • More than 1 PTBD catheter is placed at intervention.

Sites / Locations

  • ErasmusMCRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention

Standard of Care

Arm Description

flushing of internal external PTBD catheter 3 times a day

no flushing of PTBD catheter

Outcomes

Primary Outcome Measures

time-to-symptom-onset in patients with an internal external PTBD catheter without daily flushing compared to patients with an internal external PTBD catheter who daily flush the catheter
time-to-symptom-onset

Secondary Outcome Measures

Full Information

First Posted
June 1, 2021
Last Updated
August 1, 2022
Sponsor
Erasmus Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT04915703
Brief Title
Flushing of Internalized Percutaneous Transhepatic Biliary Drainage Catheters
Acronym
FLUSH
Official Title
Flushing of Internalized Percutaneous Transhepatic Biliary Drainage Catheters
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Recruiting
Study Start Date
June 1, 2022 (Actual)
Primary Completion Date
July 1, 2025 (Anticipated)
Study Completion Date
July 1, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Erasmus Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Percutaneous transhepatic biliary drainage (PTBD) is a drainage method for biliary obstruction. Patients with a PTBD catheter often need multiple re-interventions because of symptoms of catheter obstruction such as pain, jaundice, pruritus, leakage and/or fever. The onset of these symptoms results in hospital visits, opening of the external catheter of an internal external PTBD and re-interventions. The investigators hypothesize that daily flushing of an internal external biliary catheter will increase the time-to-symptom-onset.
Detailed Description
Bile is synthesized and secreted by the liver and transported into the peripheral bile ducts, to the left or right hepatic duct which join together in the common hepatic duct and more distally in the common bile duct. Secreted bile is stored in the gall bladder. During a meal, the bile is secreted into the duodenum. Obstruction of the biliary tract will result in cholestasis with symptoms as jaundice and pruritus and cholangitis in case of infection, usually related to prior biliary intervention. Causes of biliary obstruction are benign or malignant. Percutaneous transhepatic biliary drainage (PTBD) is a drainage method for biliary obstruction. The procedure starts with percutaneous puncture under fluoroscopic or ultrasound guidance and cannulation of the peripheral biliary tree, which is confirmed by contrast injection in the biliary tree. The needle will be exchanged for a guidewire which can be advanced into the biliary tract. When the correct position is reached, a drainage catheter with side holes is placed. There are two types of PTBD techniques: placement of an external biliary drain and placement of an internal external biliary drain. The external biliary drain is positioned in the bile duct above a stenosis and drains the bile externally into a bag outside the patient. Capping of an external biliary drain will stop the drainage of bile into the bag and forces the bile to drain towards the digestive tract. The internal external biliary drain is placed in the bile duct and the tip of the internal external biliary drain is localised in the duodenum allowing both bile flow through the drain to the digestive tract (internal) or into the bag (external). Capping of an internal external biliary drain will stop the external drainage and results in internal drainage only. Complications of PTBD are bleeding (usually during or shortly after the procedure), infection (cholangitis, abscess, peritonitis, cholecystitis, pancreatitis), catheter obstruction and catheter dislocation(1). Catheter obstruction will result in cholestasis resulting in jaundice, drain leakage and finally cholangitis. The exact prevalence of PTBD catheter obstruction is not described in literature, however the prevalence of cholangitis in patients with a PTBD catheter is reported as high as 59%(2). Subsequently, the PTBD catheter often needs a revision (re-intervention), i.e. exchanging the catheter for a new one. If catheter obstruction is assessed during re-intervention, attempts can be made to remove the obstruction or the obstructed PTBD catheter can be exchanged for a new PTBD catheter. After PTBD catheter placement, flushing of the PTBD catheter is not standard protocol in our center. In clinical practice, when obstruction of PTBD catheter occurs, the study team will advise patients to start with daily flushing of the PTBD catheter which the investigators believe will decrease the extent of obstruction and omits re-intervention. The investigators performed a literature search and the investigators did not find any clinical trial on the efficacy of flushing of PTBD catheters. Guidelines of the Society of Interventional Radiology on percutaneous biliary drainage do not mention flushing of the catheter(1). The investigators did find some publications in which an advice with regard to flushing of a PTBD catheter was mentioned, however without any scientific substantiation(3-7). There is no scientific evidence for or against PTBD catheter flushing. Flushing is a simple, low-cost and low-risk procedure. Complications or side-effects of PTBD catheter flushing are not reported in literature. PTBD re-interventions on the other hand are associated with risks and are invalidating for the patient. The investigators hypothesize that daily flushing of an internal external biliary catheter will increase the time-to-symptom-onset requiring hospital visits and re-interventions in this patient group.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bile Duct Obstruction
Keywords
bile duct, obstruction

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Non-blinded randomized controlled trial with 1:1 allocation
Masking
None (Open Label)
Masking Description
open
Allocation
Randomized
Enrollment
38 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
flushing of internal external PTBD catheter 3 times a day
Arm Title
Standard of Care
Arm Type
No Intervention
Arm Description
no flushing of PTBD catheter
Intervention Type
Procedure
Intervention Name(s)
Flushing of PTBD catheter
Intervention Description
flushing of internal external PTBD catheter 3 times a day
Primary Outcome Measure Information:
Title
time-to-symptom-onset in patients with an internal external PTBD catheter without daily flushing compared to patients with an internal external PTBD catheter who daily flush the catheter
Description
time-to-symptom-onset
Time Frame
12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient with obstruction of the bile duct(s) planned for internal external PTBD; Proficient in Dutch language; Written informed consent. Exclusion Criteria: Age < 18 years; No informed consent; Pregnancy; Obstruction caused by gall stones; External PTBD catheter (without internalization); Patient has already a PTBD catheter; More than 1 PTBD catheter is placed at intervention.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
laurens Groenendijk
Phone
31 0 7033612
Email
l.groenendijk@erasmusmc.nl
First Name & Middle Initial & Last Name or Official Title & Degree
Louise van Dijk
Phone
31 10 7033612
Email
imaging.trialbureau@erasmusmc.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
laurens Groenendijk
Organizational Affiliation
Erasmus Medical Center
Official's Role
Study Director
Facility Information:
Facility Name
ErasmusMC
City
Rotterdam
State/Province
Zuid Holland
ZIP/Postal Code
3015CE
Country
Netherlands
Individual Site Status
Recruiting

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Flushing of Internalized Percutaneous Transhepatic Biliary Drainage Catheters

We'll reach out to this number within 24 hrs